Skip to content

Influencing Factors of New-Onset Atrial Fibrillation in Sepsis Patients and Construction of a Nomogram Prediction Model: Based on LASSO Regression

Influencing Factors of New-Onset Atrial Fibrillation in Sepsis Patients and Construction of a Nomogram Prediction Model: Based on LASSO Regression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123237
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for sepsis; 2.Meets the diagnostic criteria for atrial fibrillation; 3.Survival time after admission > 24 hours; 4.Age >18 years; 5.Clinical data are complete;

Exclusion criteria

Exclusion criteria: 1.Congenital heart disease; 2.Pregnancy or lactation period; 3.Chronic or permanent atrial fibrillation; 4.Immune dysfunction; 5.Cognitive dysfunction;

Design outcomes

Primary

MeasureTime frame
Incidence of new-onset atrial fibrillation during the study period;

Secondary

MeasureTime frame
Demographic characteristics (age, sex, smoking history, alcohol history);Underlying diseases (chronic obstructive pulmonary disease, heart failure, ischemic heart disease, cerebrovascular disease, malignancy, etc.);Scoring tools (APACHE II score, SOFA score);Intervention therapies (mechanical ventilation duration/parameters, continuous renal replacement therapy, ECMO, IABP, etc.);Medication use (digoxin, anticholinergic drugs, xanthine derivatives, amiodarone, vasopressor agents, etc.);Inflammatory markers (complete blood count, procalcitonin, interleukin-6, tumor necrosis factor-alpha);Cardiac function markers (creatine kinase isoenzyme, cardiac troponin I, NT-proBNP);Coagulation function (PT, APTT, FIB);Hepatic and renal function, electrolyte markers (creatinine, glomerular filtration rate, potassium, liver enzymes);

Countries

China

Contacts

Public ContactOu Weiliang

Affiliated Hospital of Guangdong Medical University

545370301@qq.com+86 759 2387441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026